Abstract:Based on a structural family of thirty-two NR2B-selective N-Methyl-D-Aspartate receptor (NMDAR) antagonists, two phenylpiperazine derivatives labeled C37 and C39 were conceived thanks to molecular modeling techniques, as novel NMDAR inhibitors exhibiting the highest analgesic activities (of pIC50 order) against neuropathic pain, with excellent ADME-toxicity profiles, and good levels of molecular stability towards the targeted protein of NMDA receptor. Initially, the quantitative structure-activity relationships (QSARs) models were developed using multiple linear regression (MLR), partial least square regression (PLSR), multiple non-linear regression (MNLR), and artificial neural network (ANN) techniques, revealing that analgesic activity was strongly correlated with dipole moment, octanol/water partition coefficient, Oxygen mass percentage, electronegativity, and energy of the lowest unoccupied molecular orbital, whose the correlation coefficients of generated models were: 0.860, 0.758, 0.885 and 0.977, respectively. The predictive capacity of each model was evaluated by an external validation with correlation coefficients of 0.703, 0.851, 0.778, and 0.981 respectively, followed by a cross-validation technique with the leave-one-out procedure (CVLOO) with Q2cv of 0.785, more than Y-randomization test, and applicability domain (AD), in addition to Fisher's and Student's statistical tests. Thereafter, ten novel molecules were designed based on MLR QSAR model, then predicted with their ADME-Toxicity profiles and subsequently examined for their similarity to the drug candidates. Finally, two of the most active compounds (C37 and C39) were chosen for molecular docking and molecular dynamics (MD) investigations during 100 ns of MD simulation time in complex with the targeted protein of NMDA receptor (5EWJ.pdb).

Structural Insight on Interaction of NMDA receptor with fentanyl, ketamine and Isoflurane: A Computational Study to Unravel Mode of Binding

Structure-Based Exploration of Sevoflurane Binding Sites in Cognition-Related Synaptotagmin-1

Structural insights into binding of therapeutic channel blockers in NMDA receptors

Anesthetic Binding Induced Motion of GABAA Receptors Revealed by Coarse-Grained Molecular Dynamics Simulations

Structural basis of ketamine action on human NMDA receptors

Filling The Gap In Understanding The Mechanism Of Gaba(A)R And Propofol Using Computational Approaches

Allosteric inhibition of NMDA receptors by low dose ketamine

An In Silico Investigation of the Molecular Interactions between Volatile Anesthetics and Actin

Allosteric Site Mediates Inhibition of Tonic NMDA Receptor Activity by Low Dose Ketamine.

In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigations

Binding Mode Analyses of NAP Derivatives As Mu Opioid Receptor Selective Ligands Through Docking Studies and Molecular Dynamics Simulation

Investigating the Mechanism of Kainate Receptor and Identifying its Inhibitors Using In-Silico Techniques

Characterization of binding kinetics and intracellular signaling of new psychoactive substances targeting cannabinoid receptor using transition-based reweighting method

Ketamine: More than Just NMDA Blocker

Molecular modeling on solvent effect and interaction mechanism of fentanyl analogs to mu-opioid receptor.

Binding Affinity and Mechanisms of Potential Antidepressants Targeting Human NMDA Receptors

Basic metabolic and vascular effects of ketamine and its interaction with fentanyl

Probing the Membrane-Access Pathway of NMDA Receptors with Ketamine Enantiomers

A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists

Mechanisms and Energetics of Potassium Channel Block by Local Anesthetics and Antifungal Agents.

The Role of NMDARs in the Anesthetic and Antidepressant Effects of Ketamine.